According to US federal health officials, the U.S. will require visitors from China to show a COVID-negative test report ahead of flying to the country, after Beijing's quick determination to ease strict Coronavirus-linked restrictions to curb the virus spread....
On Sunday, Kevin Munoz, the White House Assistant Press Secretary, said Joseph R. Biden, the United States President, will get the updated Coronavirus vaccine booster dose on October 25. The American President got his second COVID-19 booster on 30th...
The US Centers for Disease Control and Prevention recently signed off that American kids as young as five-year-olds can now receive the Omicron-tailored Coronavirus booster doses produced by Pfizer and Moderna, a step that would expand the US administration’s...
On Monday, the US Centers for Disease Control said it would no longer preserve a list of COVID Travel advisories for destinations all over the world, another indication of returning to pre-pandemic normality even as approximately 1450 people worldwide...
The U.S. CDC anticipates pediatric bivalent Coronavirus jabs as booster shots for 5–11-year-olds by mid-October. The new booster dose will target two versions of the lethal SARS-CoV-2 – the original one and the most contagious BA.5 and BA.5 Omicron...
On Wednesday, the US FDA approved the first modification on COVID-19 jabs since they’re introduced late in 2020, setting up millions of US people to get new additional shots targeting now dominant Omicron sub-variants of SARS-CoV-2, labeled as BA.4...
On Friday, Novavax, Gaithersburg, Maryland-based biotechnology firm, announced that the U.S. federal health regulator FDA has granted approval to its COVID-19 vaccine for emergency use (EUA) in adolescents. Fortunately, it’s the fourth COVID-19 jab available in America, and US...
Lloyd Austin, the U.S. Secretary of Defense, said he tested positive for Coronavirus on Monday morning, the second time in 2022 to have contracted the lethal virus. Mr. Austin said in a statement that he was experiencing ‘mild symptoms’...
On Wednesday, Pfizer Inc., a New York-headquartered pharmaceutical firm, and Mainz, Germany-based biotechnology firm, BioNTech SE, said that they’d begun a mid-stage trial of a modified Coronavirus jab that targets both the initial as well as the Omicron sublineage...
According to health officials, the United States is acquiring another vaccine to treat the fatal disease caused by Coronavirus as the U.S. FDA on July 13 said OK to Novavax doses for adults. The COVID-19 jab manufactured by Novavax,...
